rhPRG4 was incubated with β1-3 galactosidase and α2-3, 6, 8 neuraminidase (New England BioLabs, Ipswich, MA, US) separately or in combination (simultaneously) according to the manufacturer’s instructions. FLSs were prepared (Ren et al., 2021 (link)) from normal individuals (n = 3) and OA patients (n = 3) and were incubated with 15 mg of rhPRG4 (intact, deglycosylated with α2-3, 6, 8 neuraminidase, β1-3 galactosidase, or both) for 48 h at 37°C at 5% CO2. The effect of the deglycosylation was monitored as a shift in the migration of rhPRG4 using SDS-PAGE (Supplementary Figure S3).
Free full text: Click here